Does LOSARTAN Cause Lung neoplasm malignant? 37 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Lung neoplasm malignant have been filed in association with LOSARTAN (Losartan Potassium). This represents 0.2% of all adverse event reports for LOSARTAN.
37
Reports of Lung neoplasm malignant with LOSARTAN
0.2%
of all LOSARTAN reports
10
Deaths
9
Hospitalizations
How Dangerous Is Lung neoplasm malignant From LOSARTAN?
Of the 37 reports, 10 (27.0%) resulted in death, 9 (24.3%) required hospitalization, and 2 (5.4%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LOSARTAN. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does LOSARTAN Cause?
Drug ineffective (1,640)
Dizziness (1,553)
Headache (1,256)
Dyspnoea (1,185)
Malaise (1,149)
Hypotension (1,139)
Fatigue (1,116)
Acute kidney injury (1,100)
Cough (1,073)
Blood pressure increased (950)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which LOSARTAN Alternatives Have Lower Lung neoplasm malignant Risk?
LOSARTAN vs LOSARTAN\LOSARTAN
LOSARTAN vs LOTEPREDNOL ETABONATE
LOSARTAN vs LOTEPREDNOL ETABONATE\TOBRAMYCIN
LOSARTAN vs LOTILANER
LOSARTAN vs LOVASTATIN